LD-2 disclosure · 1st Quarter - Report
INTELLIA THERAPEUTICS
Income$50Kfee reported
Client
- Description
- biotechnology company
- Location
- Massachusetts · United States of America
Registrant
- Description
- lobbying firm
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
1 issueHealth Issues
Education and advocacy related to gene therapy. Education around COVID-19 therapies. H.R.3, Lower Drug Costs Now Act of 2019. S.2543, Prescription Drug Pricing Reduction Act of 2019. H.R.19, Lower Costs, More Cures Act of 2019.
LobbyistsMATHEW LAPINSKI · MARC NUMEDAHL · KATHERINE DAPPER · JASON BENJAMIN VAN PELT · JASON GLEASON
TargetedSENATE · HOUSE OF REPRESENTATIVES · Executive Office of the President (EOP) · Office of the Vice President of the United States